Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Milton S. Hershey Medical Center
Sponsor:
Information provided by (Responsible Party):
Jeffrey J. Pu, MD, PhD, Milton S. Hershey Medical Center
ClinicalTrials.gov Identifier:
NCT01439750
First received: August 16, 2011
Last updated: November 21, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)